FAK Inhibitors

Scientists Harness Mouth’s GAS6-AXL Pathway to Reduce Skin Scarring

Preclinical evidence shows that GAS6-driven AXL activation suppresses FAK to reduce scarring in mouse skin, paving the way for human trials